From the data provided, the forecasted values for cardiac glycosides use in Canada, in DDD per 1000 persons per day, show a consistent downward trend over the next five years. The values are as follows:
- 2024: 600.0
- 2025: 500.0
- 2026: 400.0
- 2027: 400.0
- 2028: 300.0
Year-on-Year Variation
- 2024 to 2025: -16.67%
- 2025 to 2026: -20.00%
- 2026 to 2027: 0.00%
- 2027 to 2028: -25.00%
Compound Annual Growth Rate (CAGR)
Over the last 5 years: -15.03%
Given the declining trend, it's important to monitor advancements in alternative treatments, changes in clinical guidelines, and evolving patient and healthcare provider preferences. Further study on the impact of these elements can guide future strategies effectively.
